You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 32 Issue 10

November 2010

Volume 32, Issue 10

Pages 1211–1295

  1. Meta-analysis

    1. Top of page
    2. Meta-analysis
    3. Original articles
    4. Letters to the Editors
    1. You have free access to this content
      Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis (pages 1211–1221)

      M. O. Rakoski, A. G. Singal, M. A. M. Rogers and H. Conjeevaram

      Version of Record online: 23 SEP 2010 | DOI: 10.1111/j.1365-2036.2010.04467.x

    2. You have free access to this content
  2. Original articles

    1. Top of page
    2. Meta-analysis
    3. Original articles
    4. Letters to the Editors
    1. You have free access to this content
      The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy (pages 1228–1239)

      S. Lichtiger, D. G. Binion, D. C. Wolf, D. H. Present, A. G. Bensimon, E. Wu, A. P. Yu, A. T. Cardoso, J. Chao, P. M. Mulani, K. G. Lomax and J. D. Kent

      Version of Record online: 28 SEP 2010 | DOI: 10.1111/j.1365-2036.2010.04466.x

    2. You have free access to this content
    3. You have free access to this content
      The effects of dose and timing of esomeprazole administration on 24-h, daytime and night-time acid inhibition in healthy volunteers (pages 1249–1256)

      C. Wilder-Smith, K. Röhss, S. Bokelund Singh, M. Sagar and P. Nagy

      Version of Record online: 28 SEP 2010 | DOI: 10.1111/j.1365-2036.2010.04469.x

    4. You have free access to this content
    5. You have free access to this content
      The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis (pages 1266–1274)

      S. Gaddam, S. Wani, H. Ahmed, P. Maddur, S. B. Hall, N. Gupta, S. R. Puli, A. Higbee, A. Rastogi, A. Bansal and P. Sharma

      Version of Record online: 28 SEP 2010 | DOI: 10.1111/j.1365-2036.2010.04468.x

      Corrected by:

      Corrigenda

      Vol. 34, Issue 11-12, 1356, Version of Record online: 16 NOV 2011

    6. You have free access to this content
      Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials (pages 1275–1291)

      B. M. R. Spiegel, R. Bolus, N. Agarwal, G. Sayuk, L. A. Harris, S. Lucak, E. Esrailian, W. D. Chey, A. Lembo, H. Karsan, K. Tillisch, J. Talley and L. Chang

      Version of Record online: 28 SEP 2010 | DOI: 10.1111/j.1365-2036.2010.04464.x

  3. Letters to the Editors

    1. Top of page
    2. Meta-analysis
    3. Original articles
    4. Letters to the Editors
    1. You have free access to this content
      Antioxidants for liver disease (pages 1292–1293)

      R. Moreno-Otero and M. Trapero-Marugán

      Version of Record online: 19 OCT 2010 | DOI: 10.1111/j.1365-2036.2010.04441.x

    2. You have free access to this content
      Antioxidants for liver disease: authors’ reply (pages 1293–1294)

      G. Bjelakovic, L. L. Gluud, D. Nikolova, M. Bjelakovic, A. Nagorni and C. Gluud

      Version of Record online: 19 OCT 2010 | DOI: 10.1111/j.1365-2036.2010.04481.x

    3. You have free access to this content
      Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates (pages 1294–1295)

      S. J. Halpin, P. J. Hamlin and A. C. Ford

      Version of Record online: 19 OCT 2010 | DOI: 10.1111/j.1365-2036.2010.04478.x

SEARCH

SEARCH BY CITATION